CoChat

Prevalence of sexual dimorphism in mammalian phenotypic traits

Open access
Karp, Natasha A., Mason, Jeremy, Beaudet, Arthur L., Benjamini, Yoav, Bower, Lynette, Braun, Robert E., Brown, Steve D.M., Chesler, Elissa J., Dickinson, Mary E., Flenniken, Ann M., Fuchs, Helmut, Angelis, Martin Hrabe de, Gao, Xiang, Guo, Shiying, Greenaway, Simon, Heller, Ruth, Herault, Yann, Justice, Monica J., Kurbatova, Natalja, Lelliott, Christopher J., Lloyd, K.C. Kent, Mallon, Ann-Marie, Mank, Judith E., Masuya, Hiroshi, McKerlie, Colin, Meehan, Terrence F., Mott, Richard F., Murray, Stephen A., Parkinson, Helen, Ramirez-Solis, Ramiro, Santos, Luis, Seavitt, John R., Smedley, Damian, Sorg, Tania, Speak, Anneliese O., Steel, Karen P., Svenson, Karen L., International Mouse Phenotyping Consortium, Obata, Yuichi, Suzuki, Tomohiro, Tamura, Masaru, Kaneda, Hideki, Furuse, Tamio, Kobayashi, Kimio, Miura, Ikuo, Yamada, Ikuko, Tanaka, Nobuhiko, Yoshiki, Atsushi, Ayabe, Shinya, Clary, David A., Tolentino, Heather A., Schuchbauer, Michael A., Tolentino, Todd, Aprile, Joseph Anthony, Pedroia, Sheryl M., Kelsey, Lois, Vukobradovic, Igor, Berberovic, Zorana, Owen, Celeste, Qu, Dawei, Guo, Ruolin, Newbigging, Susan, Morikawa, Lily, Law, Napoleon, Shang, Xueyuan, Feugas, Patricia, Wang, Yanchun, Eskandarian, Mohammad, Zhu, Yingchun, Nutter, Lauryl M. J., Penton, Patricia, Laurin, Valerie, Clarke, Shannon, Lan, Qing, Sohel, Khondoker, Miller, David, Clark, Greg, Hunter, Jane, Cabezas, Jorge, Bubshait, Mohammed, Carroll, Tracy, Tondat, Sandra, MacMaster, Suzanne, Pereira, Monica, Gertsenstein, Marina, Danisment, Ozge, Jacob, Elsa, Creighton, Amie, Sleep, Gillian, Clark, James, Teboul, Lydia, Fray, Martin, Caulder, Adam, Loeffler, Jorik, Codner, Gemma, Cleak, James, Johnson, Sara, Szoke-Kovacs, Zsombor, Radage, Adam, Maritati, Marina, Mianne, Joffrey, Gardiner, Wendy, Allen, Susan, Cater, Heather, Stewart, Michelle, Keskivali-Bond, Piia, Sinclair, Caroline, Brown, Ellen, Doe, Brendan, Wardle-Jones, Hannah, Grau, Evelyn, Griggs, Nicola, Woods, Mike, Kundi, Helen, Griffiths, Mark N. D., Kipp, Christian, Melvin, David G., Raj, Navis P. S., Holroyd, Simon A., Gannon, David J., Alcantara, Rafael, Galli, Antonella, Hooks, Yvette E., Tudor, Catherine L., Green, Angela L., Kussy, Fiona L., Tuck, Elizabeth J., Siragher, Emma J., Maguire, Simon A., Lafont, David T., Vancollie, Valerie E., Pearson, Selina A., Gates, Amy S., Sanderson, Mark, Shannon, Carl, Anthony, Lauren F. E., Sumowski, Maksymilian T., McLaren, Robbie S. B., Swiatkowska, Agnieszka, Isherwood, Christopher M., Cambridge, Emma L, Wilson, Heather M., Caetano, Susana S., Mazzeo, Cecilia Icoresi, Dabrowska, Monika H., Lillistone, Charlotte, Estabel, Jeanne, Maguire, Anna Karin B., Roberson, Laura-Anne, Pavlovic, Guillaume, Birling, Marie-Christine, Marie, Wattenhofer-Donze, Jacquot, Sylvie, Ayadi, Abdel, Ali-Hadji, Dalila, Charles, Philippe, André, Philippe, Le Marchand, Elise, El Amri, Amal, Vasseur, Laurent, Aguilar-Pimentel, Antonio, Becker, Lore, Treise, Irina, Moreth, Kristin, Stoeger, Tobias, Amarie, Oana V., Neff, Frauke, Wurst, Wolfgang, Bekeredjian, Raffi, Ollert, Markus, Klopstock, Thomas, Calzada-Wack, Julia, Marschall, Susan, Brommage, Robert, Steinkamp, Ralph, Lengger, Christoph, Östereicher, Manuela A., Maier, Holger, Stoeger, Claudia, Leuchtenberger, Stefanie, Yildrim, AliÖ, Garrett, Lillian, Hölter, Sabine M, Zimprich, Annemarie, Seisenberger, Claudia, Bürger, Antje, Graw, Jochen, Eickelberg, Oliver, Zimmer, Andreas, Wolf, Eckhard, Busch, Dirk H, Klingenspor, Martin, Schmidt-Weber, Carsten, Gailus-Durner, Valérie, Beckers, Johannes, Rathkolb, Birgit, Rozman, Jan, Wakana, Shigeharu, West, David, Wells, Sara, Westerberg, Henrik, Yaacoby, Shay, White, Jacqueline K. · 2017 · Nature Communications

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Abstract

The role of sex in biomedical studies has often been overlooked, despite evidence of sexually dimorphic effects in some biological studies. Here, we used high-throughput phenotype data from 14,250 wildtype and 40,192 mutant mice (representing 2,186 knockout lines), analysed for up to 234 traits, and found a large proportion of mammalian traits both in wildtype and mutants are influenced by sex. This result has implications for interpreting disease phenotypes in animal models and humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms15475

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Sex as a biological variable in control data. The role of sex in explaining variation in phenotypes of wildtype mice as assessed using data from the IMPC. (a,b) The proportion of experiments where sex had a significant role in wildtype phenotype. (a) Categorical data sets (n=545). (b) Continuous data sets (n=903). (c,d) The distribution of classifications when analysed by institute (c: categorical data sets, d: continuous data sets). BCM: Baylor College of Medicine, HMGU: Helmholtz Zentrum Munich, ICS: Institut Clinique de la Souris, JAX: The Jackson Laboratory, Harwell: Medical Research Council Harwell, NING: Nanjing University, RBRC: RIKEN BioResource Centre, TCP: The Centre for Phenogenomics, UC Davis: University of California, Davis, and WTSI: Wellcome Trust Sanger Institute.
Figure 1 Sex as a biological variable in control data. The role of sex in explaining variation in phenotypes of wildtype mice as assessed using data from the IMPC. (a,b) The proportion of experiments where sex had a significant role in wildtype phenotype. (a) Categorical data sets (n=545). (b) Continuous data sets (n=903). (c,d) The distribution of classifications when analysed by institute (c: categorical data sets, d: continuous data sets). BCM: Baylor College of Medicine, HMGU: Helmholtz Zentrum Munich, ICS: Institut Clinique de la Souris, JAX: The Jackson Laboratory, Harwell: Medical Research Council Harwell, NING: Nanjing University, RBRC: RIKEN BioResource Centre, TCP: The Centre for Phenogenomics, UC Davis: University of California, Davis, and WTSI: Wellcome Trust Sanger Institute.CC BY · PubMed Central
Figure 2 Sex as a biological variable in wildtype phenotypic continuous data when exploring absolute difference in phenotypes. Exploration of how often sex was significant at explaining variation at a 5% FDR in an individual experiment using IMPC wildtype data for continuous traits. The analysis assessed the role of sex in the trait of interest, at a centre level, as an absolute phenotype since weight was not included as a covariate. For all sections, green indicates the phenotype was greater in the female, magenta indicates the trait was greater in the males, white indicates missing data, and grey indicates there was no significant sex effect. (a) Pie chart showing the proportion of data sets where sex was a significant source of variation (n=903). (b) Comparison of the reproducibility of the sex differences in the traits monitored within the intra-peritoneal glucose tolerance test across ten phenotyping centres. (c) Bar graph showing the proportion of data sets where sex was a significant source of variation by procedure. CSD indicates combined SHIRPA and dysmorphology screen, DEXA: dual-energy X-ray absorptiometry, and PPI: acoustic startle and pre-pulse inhibition. (d) Comparison of the consistency of the role of sex in the traits monitored within the DEXA procedure across ten phenotyping centres. BCM: Baylor College of Medicine, HMGU: Helmholtz Zentrum Munich, ICS: Institut Clinique de la Souris, JAX: The Jackson Laboratory, Harwell: Medical Research Council Harwell, NING: Nanjing University, RBRC: RIKEN BioResource Centre, TCP: The Centre for Phenogenomics, UC Davis: University of California, Davis and WTSI: Wellcome Trust Sanger Institute.
Figure 2 Sex as a biological variable in wildtype phenotypic continuous data when exploring absolute difference in phenotypes. Exploration of how often sex was significant at explaining variation at a 5% FDR in an individual experiment using IMPC wildtype data for continuous traits. The analysis assessed the role of sex in the trait of interest, at a centre level, as an absolute phenotype since weight was not included as a covariate. For all sections, green indicates the phenotype was greater in the female, magenta indicates the trait was greater in the males, white indicates missing data, and grey indicates there was no significant sex effect. (a) Pie chart showing the proportion of data sets where sex was a significant source of variation (n=903). (b) Comparison of the reproducibility of the sex differences in the traits monitored within the intra-peritoneal glucose tolerance test across ten phenotyping centres. (c) Bar graph showing the proportion of data sets where sex was a significant source of variation by procedure. CSD indicates combined SHIRPA and dysmorphology screen, DEXA: dual-energy X-ray absorptiometry, and PPI: acoustic startle and pre-pulse inhibition. (d) Comparison of the consistency of the role of sex in the traits monitored within the DEXA procedure across ten phenotyping centres. BCM: Baylor College of Medicine, HMGU: Helmholtz Zentrum Munich, ICS: Institut Clinique de la Souris, JAX: The Jackson Laboratory, Harwell: Medical Research Council Harwell, NING: Nanjing University, RBRC: RIKEN BioResource Centre, TCP: The Centre for Phenogenomics, UC Davis: University of California, Davis and WTSI: Wellcome Trust Sanger Institute.CC BY · PubMed Central
Figure 3 Sex as a biological variable after accounting for the potential confounding effect of body weight. Assessment of the role of sex within an experiment using IMPC wildtype data at a 5% FDR. The analysis assessed the role of sex in the trait of interest, at a centre level. For continuous traits, this was computed as a relative phenotype since weight was included as a covariate. For all sections, green indicates the phenotype was greater in the females, magenta indicates the trait was greater in the males, white indicates missing data and grey indicates there was no significant sex effect. (a) Bar graph showing the proportion of data sets where sex was a significant source of variation by procedure for continuous traits. CSD indicates combined SHIRPA and dysmorphology screen, DEXA: dual-energy X-ray absorptiometry and PPI: acoustic startle and pre-pulse inhibition. (b) Bar graph showing the role of sex by procedure for categorical traits where CSD indicates combined SHIRPA and dysmorphology screen. (c) Comparison of the reproducibility of the sex differences in the traits monitored within the DEXA procedure across ten phenotyping centres. (d) Comparison of the consistency of the role of sex in the traits monitored within the intra-peritoneal glucose tolerance test across ten phenotyping centres. BCM: Baylor College of Medicine, HMGU: Helmholtz Zentrum Munich, ICS: Institut Clinique de la Souris, JAX: The Jackson Laboratory, Harwell: Medical Research Council Harwell, NING: Nanjing University, RBRC: RIKEN BioResource Centre, TCP: The Centre for Phenogenomics, UC Davis: University of California, Davis and WTSI: Wellcome Trust Sanger Institute.
Figure 3 Sex as a biological variable after accounting for the potential confounding effect of body weight. Assessment of the role of sex within an experiment using IMPC wildtype data at a 5% FDR. The analysis assessed the role of sex in the trait of interest, at a centre level. For continuous traits, this was computed as a relative phenotype since weight was included as a covariate. For all sections, green indicates the phenotype was greater in the females, magenta indicates the trait was greater in the males, white indicates missing data and grey indicates there was no significant sex effect. (a) Bar graph showing the proportion of data sets where sex was a significant source of variation by procedure for continuous traits. CSD indicates combined SHIRPA and dysmorphology screen, DEXA: dual-energy X-ray absorptiometry and PPI: acoustic startle and pre-pulse inhibition. (b) Bar graph showing the role of sex by procedure for categorical traits where CSD indicates combined SHIRPA and dysmorphology screen. (c) Comparison of the reproducibility of the sex differences in the traits monitored within the DEXA procedure across ten phenotyping centres. (d) Comparison of the consistency of the role of sex in the traits monitored within the intra-peritoneal glucose tolerance test across ten phenotyping centres. BCM: Baylor College of Medicine, HMGU: Helmholtz Zentrum Munich, ICS: Institut Clinique de la Souris, JAX: The Jackson Laboratory, Harwell: Medical Research Council Harwell, NING: Nanjing University, RBRC: RIKEN BioResource Centre, TCP: The Centre for Phenogenomics, UC Davis: University of California, Davis and WTSI: Wellcome Trust Sanger Institute.CC BY · PubMed Central
Figure 4 Role of sex as a modifier of the genotype effect. The role of sex in explaining variation in phenotypes of knockout mice as assessed using data from the IMPC. (a) Classification for categorical data sets (n=1,220) with a genotype effect at 20% FDR. (b) Classification for continuous data sets (n=7,929) with a genotype effect at 5% FDR. The ‘Cannot classify’ effect arises when statistically an interaction is detected between sex and genotype but the model output is insufficient to specify where the interaction arises. The ‘Genotype effect with no sex effect’ effect is the classification when the null hypothesis of no genotype*sex interaction was not rejected; this may be because the effect is the same across sexes, or due to a lack of power to detect the differential effect across sexes. (c,d) Comparison of SD hit rate for each screen with more than 35 genotype significant hits (c) Categorical traits. (d) Continuous traits. IPGTT: intra-peritoneal glucose tolerance test; ECG: electrocardiogram; DEXA: dual-energy X-ray absorptiometry; CSD: combined SHIRPA and dysmorphology; PPI: acoustic startle and pre-pulse inhibition.
Figure 4 Role of sex as a modifier of the genotype effect. The role of sex in explaining variation in phenotypes of knockout mice as assessed using data from the IMPC. (a) Classification for categorical data sets (n=1,220) with a genotype effect at 20% FDR. (b) Classification for continuous data sets (n=7,929) with a genotype effect at 5% FDR. The ‘Cannot classify’ effect arises when statistically an interaction is detected between sex and genotype but the model output is insufficient to specify where the interaction arises. The ‘Genotype effect with no sex effect’ effect is the classification when the null hypothesis of no genotype*sex interaction was not rejected; this may be because the effect is the same across sexes, or due to a lack of power to detect the differential effect across sexes. (c,d) Comparison of SD hit rate for each screen with more than 35 genotype significant hits (c) Categorical traits. (d) Continuous traits. IPGTT: intra-peritoneal glucose tolerance test; ECG: electrocardiogram; DEXA: dual-energy X-ray absorptiometry; CSD: combined SHIRPA and dysmorphology; PPI: acoustic startle and pre-pulse inhibition.CC BY · PubMed Central
Figure 5 Role of sex as a modifier of the genotype effect with more stringent criteria. Exploration of the role of sex in modifying the genotype effect in studies of continuous traits of knockout mice data from the IMPC. (a) Distribution of sex effect in the genotype significant data sets when using a 1% FDR. Overall, 110,586 data sets were tested and 3.4% (3,719) were significant for the stage 1 genotype effect. Of these, 12% (n=466) were classed as SD. (b) Distribution of sex effect in the genotype significant data sets when processing only multi-batch data sets at a 5% FDR. A total of 46,925 data sets were tested and 8.9% (3,719) were significant for the stage 1 genotype effect. Of these, 13.8% (n=575) were classed as SD.
Figure 5 Role of sex as a modifier of the genotype effect with more stringent criteria. Exploration of the role of sex in modifying the genotype effect in studies of continuous traits of knockout mice data from the IMPC. (a) Distribution of sex effect in the genotype significant data sets when using a 1% FDR. Overall, 110,586 data sets were tested and 3.4% (3,719) were significant for the stage 1 genotype effect. Of these, 12% (n=466) were classed as SD. (b) Distribution of sex effect in the genotype significant data sets when processing only multi-batch data sets at a 5% FDR. A total of 46,925 data sets were tested and 8.9% (3,719) were significant for the stage 1 genotype effect. Of these, 13.8% (n=575) were classed as SD.CC BY · PubMed Central
Figure 6 Control of type-one errors for continuous traits in the stage 1 assessment of genotype and stage 2 assessment of genotype*sex interaction. Resampling studies of wildtype data, to build data sets with ‘mock’ knockout animals under various phenotyping workflows, were used to assess the control of type-one errors for the statistical pipeline. (a) The stage 1 type-one error rate at a trait level at the 0.05 significance threshold as a function of workflow. (b) The stage 1 average type-one error rate for various significance thresholds and workflows. (c) The stage 2 type-one error rate at a trait level at the 0.05 significance threshold as a function of workflow. (d) The stage 2 average type-one error rate at a trait level for various significance thresholds and workflows. For a–d the one-batch workflow is represented by either B1 or a black line, a two batch workflow is represented by B2 or a red line, a three batch workflow is represented by B3 or a green line, a multiple batch workflow is represented by MB or an orange line, a dashed line represents the ideal rate, and finally a random workflow is represented by R or a blue line.
Figure 6 Control of type-one errors for continuous traits in the stage 1 assessment of genotype and stage 2 assessment of genotype*sex interaction. Resampling studies of wildtype data, to build data sets with ‘mock’ knockout animals under various phenotyping workflows, were used to assess the control of type-one errors for the statistical pipeline. (a) The stage 1 type-one error rate at a trait level at the 0.05 significance threshold as a function of workflow. (b) The stage 1 average type-one error rate for various significance thresholds and workflows. (c) The stage 2 type-one error rate at a trait level at the 0.05 significance threshold as a function of workflow. (d) The stage 2 average type-one error rate at a trait level for various significance thresholds and workflows. For a–d the one-batch workflow is represented by either B1 or a black line, a two batch workflow is represented by B2 or a red line, a three batch workflow is represented by B3 or a green line, a multiple batch workflow is represented by MB or an orange line, a dashed line represents the ideal rate, and finally a random workflow is represented by R or a blue line.CC BY · PubMed Central
Figure 7 Control of type-one errors for assessing a genotype by sex interaction in the presence of a genotype effect for continuous traits. A simulation study, to assess the stage 2 type-one error rate, where a genotype effect affecting both sexes has been added to the knockout mice as signal (as a function of standard deviation for four levels: 0.5, 1, 1.5, 2). (a) The average stage 2 type-one error rate as a function of the significance threshold. Only one level can be seen as the lines overlay each over. (b) The stage 2 type-one error rate at the trait level for the 0.05 significance threshold as a function of the signal added. Shown is a boxplot giving a five point summary (minimum, first quantile, mean, third quantile and maximum).
Figure 7 Control of type-one errors for assessing a genotype by sex interaction in the presence of a genotype effect for continuous traits. A simulation study, to assess the stage 2 type-one error rate, where a genotype effect affecting both sexes has been added to the knockout mice as signal (as a function of standard deviation for four levels: 0.5, 1, 1.5, 2). (a) The average stage 2 type-one error rate as a function of the significance threshold. Only one level can be seen as the lines overlay each over. (b) The stage 2 type-one error rate at the trait level for the 0.05 significance threshold as a function of the signal added. Shown is a boxplot giving a five point summary (minimum, first quantile, mean, third quantile and maximum).CC BY · PubMed Central
Figure 8 Role of sex as a modifier of a genotype–phenotype relationship. (a) Looking across IMPC knockout lines identified as having 10% or more traits with a significant genotype effect, the proportion of traits classed as SD varied. Data sets are classified as SD (purple) or genotype effect with no sex effect (green) where a genotype effect in a mutant line is observed. (b) For all traits identified as having a significant genotype effect for the Usp47tm1b(EUCOMM)Wtsi line (MGI:5605792), a comparison is presented of the standardized genotype effect with 95% confidence interval for each sex with no multiple comparisons correction. Standardization, to allow comparison across variables, was achieved by dividing the genotype estimate by the signal seen in the wildtype population. Shown in red are statistically significant estimates. RBC: red blood cells; BMC: bone mineral content; BMD: bone mineral density; WBC: white blood cells. (c,d) Raw data visualization for two traits in Usp47tm1b(EUCOMM)Wtsi mice identified as having a significant SD genotype effect as the effect was specific to male mice. HDL: high-density lipoprotein–cholesterol; KO: knockout, WT: wildtype. While the Usp47tm1b(EUCOMM)Wtsi line had a high proportion of SD traits, the standardized effect size (ES) change leading to a SD call observed for each trait was typically ±1 s.d. unit from the average ES. Globally for all SD calls, the ES was 0.28 (s.d.=0.38) while for Usp47tm1b(EUCOMM)Wtsi the ES was 0.18 (s.d.=0.14).
Figure 8 Role of sex as a modifier of a genotype–phenotype relationship. (a) Looking across IMPC knockout lines identified as having 10% or more traits with a significant genotype effect, the proportion of traits classed as SD varied. Data sets are classified as SD (purple) or genotype effect with no sex effect (green) where a genotype effect in a mutant line is observed. (b) For all traits identified as having a significant genotype effect for the Usp47tm1b(EUCOMM)Wtsi line (MGI:5605792), a comparison is presented of the standardized genotype effect with 95% confidence interval for each sex with no multiple comparisons correction. Standardization, to allow comparison across variables, was achieved by dividing the genotype estimate by the signal seen in the wildtype population. Shown in red are statistically significant estimates. RBC: red blood cells; BMC: bone mineral content; BMD: bone mineral density; WBC: white blood cells. (c,d) Raw data visualization for two traits in Usp47tm1b(EUCOMM)Wtsi mice identified as having a significant SD genotype effect as the effect was specific to male mice. HDL: high-density lipoprotein–cholesterol; KO: knockout, WT: wildtype. While the Usp47tm1b(EUCOMM)Wtsi line had a high proportion of SD traits, the standardized effect size (ES) change leading to a SD call observed for each trait was typically ±1 s.d. unit from the average ES. Globally for all SD calls, the ES was 0.28 (s.d.=0.38) while for Usp47tm1b(EUCOMM)Wtsi the ES was 0.18 (s.d.=0.14).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Lloyd, K. & de Jong, P. The Knockout Mouse Project (KOMP) repository. Transgenic Res. 19, 338–339 (2010).

Cited by

Items 201–258 of 258

Metadata

Authors
Karp, N. A., Mason, J., Beaudet, A. L., Benjamini, Y., Bower, L., Braun, R. E., Brown, S. D. M., Chesler, E. J., Dickinson, M. E., Flenniken, A. M., Fuchs, H., Angelis, M. H. D., Gao, X., Guo, S., Greenaway, S., Heller, R., Herault, Y., Justice, M. J., Kurbatova, N., Lelliott, C. J., Lloyd, K. C. K., Mallon, A.-M., Mank, J. E., Masuya, H., McKerlie, C., Meehan, T. F., Mott, R. F., Murray, S. A., Parkinson, H., Ramirez-Solis, R., Santos, L., Seavitt, J. R., Smedley, D., Sorg, T., Speak, A. O., Steel, K. P., Svenson, K. L., International Mouse Phenotyping Consortium, Obata, Y., Suzuki, T., Tamura, M., Kaneda, H., Furuse, T., Kobayashi, K., Miura, I., Yamada, I., Tanaka, N., Yoshiki, A., Ayabe, S., Clary, D. A., Tolentino, H. A., Schuchbauer, M. A., Tolentino, T., Aprile, J. A., Pedroia, S. M., Kelsey, L., Vukobradovic, I., Berberovic, Z., Owen, C., Qu, D., Guo, R., Newbigging, S., Morikawa, L., Law, N., Shang, X., Feugas, P., Wang, Y., Eskandarian, M., Zhu, Y., Nutter, L. M. J., Penton, P., Laurin, V., Clarke, S., Lan, Q., Sohel, K., Miller, D., Clark, G., Hunter, J., Cabezas, J., Bubshait, M., Carroll, T., Tondat, S., MacMaster, S., Pereira, M., Gertsenstein, M., Danisment, O., Jacob, E., Creighton, A., Sleep, G., Clark, J., Teboul, L., Fray, M., Caulder, A., Loeffler, J., Codner, G., Cleak, J., Johnson, S., Szoke-Kovacs, Z., Radage, A., Maritati, M., Mianne, J., Gardiner, W., Allen, S., Cater, H., Stewart, M., Keskivali-Bond, P., Sinclair, C., Brown, E., Doe, B., Wardle-Jones, H., Grau, E., Griggs, N., Woods, M., Kundi, H., Griffiths, M. N. D., Kipp, C., Melvin, D. G., Raj, N. P. S., Holroyd, S. A., Gannon, D. J., Alcantara, R., Galli, A., Hooks, Y. E., Tudor, C. L., Green, A. L., Kussy, F. L., Tuck, E. J., Siragher, E. J., Maguire, S. A., Lafont, D. T., Vancollie, V. E., Pearson, S. A., Gates, A. S., Sanderson, M., Shannon, C., Anthony, L. F. E., Sumowski, M. T., McLaren, R. S. B., Swiatkowska, A., Isherwood, C. M., Cambridge, E. L., Wilson, H. M., Caetano, S. S., Mazzeo, C. I., Dabrowska, M. H., Lillistone, C., Estabel, J., Maguire, A. K. B., Roberson, L.-A., Pavlovic, G., Birling, M.-C., Marie, W.-D., Jacquot, S., Ayadi, A., Ali-Hadji, D., Charles, P., André, P., Le Marchand, E., El Amri, A., Vasseur, L., Aguilar-Pimentel, A., Becker, L., Treise, I., Moreth, K., Stoeger, T., Amarie, O. V., Neff, F., Wurst, W., Bekeredjian, R., Ollert, M., Klopstock, T., Calzada-Wack, J., Marschall, S., Brommage, R., Steinkamp, R., Lengger, C., Östereicher, M. A., Maier, H., Stoeger, C., Leuchtenberger, S., Yildrim, A., Garrett, L., Hölter, S. M., Zimprich, A., Seisenberger, C., Bürger, A., Graw, J., Eickelberg, O., Zimmer, A., Wolf, E., Busch, D. H., Klingenspor, M., Schmidt-Weber, C., Gailus-Durner, V., Beckers, J., Rathkolb, B., Rozman, J., Wakana, S., West, D., Wells, S., Westerberg, H., Yaacoby, S., & White, J. K.
Affiliations
  • AstraZeneca (United Kingdom) (GB)
  • European Bioinformatics Institute (GB)
  • Baylor College of Medicine (US)
  • Tel Aviv University (IL)
  • University of California, Davis (US)
  • Jackson Laboratory (US)
  • Mary Lyon Centre at MRC Harwell (GB)
  • Toronto Centre for Phenogenomics (CA)
  • Helmholtz Munich (DE)
  • Model Animal Research Center (CN)
  • Hospital for Sick Children (CA)
  • Wellcome Sanger Institute (GB)
  • University College London (GB)
  • RIKEN BioResource Research Center (JP)
  • Queen Mary University of London (GB)
  • Centre National de la Recherche Scientifique (FR)
  • King's College London (GB)
  • Phénotypage et ingénierie précliniques des systèmes d’organismes modèles (FR)
  • German Center for Neurodegenerative Diseases (DE)
  • Heidelberg University (DE)
  • University of Southern Denmark (DK)
  • University of Bonn (DE)
  • Ludwig-Maximilians-Universität München (DE)
  • Technical University of Munich (DE)
  • Else Kröner Fresenius Zentrum für Ernährungsmedizin (DE)
Corresponding author
Karp, Natasha A.
ORCID
Venue
Nature Communications
Published
2017-06-26
Volume
8
Issue
1
Pages
15475-15475
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2671308999
Cited by
257
References
38
Citations by year
2026: 11 · 2025: 28 · 2024: 24 · 2023: 31 · 2022: 28 · 2021: 32 · 2020: 34 · 2019: 32 · 2018: 24 · 2017: 12
FWCI
26.15
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
  • HAL (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion, cc-by)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
  • Site cant be reached (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • National Institutes of Health (U42OD011185, UM1OD023222, UM1OD023221, U42OD012210)
  • Medical Research Council (MR/N012119/1, MC_qA137918)
  • Biotechnology and Biological Sciences Research Council (BB/M02069X/1)
  • Japan Society for the Promotion of Science (15K06815, 17K07144, 15H02755)
  • National Human Genome Research Institute (UM1HG006348)
  • National Cancer Institute (P30CA034196)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Morphological variations and asymmetry
Keywords
sexual dimorphism, sex differences, phenotypic traits, knockout mice, mouse mutants, high-throughput phenotyping, disease models
MeSH terms
Animals, Body Weight, Female, Genotype, Mammals, Phenotype, Sex Characteristics, Quantitative Trait, Heritable, Mice, Genes, Modifier

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.